Key result
AMPKalpha(2) deletion in mice resulted in a more rapid onset of ischemia-induced contracture and decreased ATP and glycogen content, but did not exacerbate impairment of postischemic contractile recovery.
Why the study?
Does AMPKalpha2 deletion alter the metabolic response and contractile function of the heart during no-flow ischemia in mice?
Does AMPKalpha2 deletion alter the metabolic response and contractile function of the heart during no-flow ischemia in mice?
AMPKalpha2 is required for the metabolic response of the heart to no-flow ischemia, and its absence leads to worse metabolic adaptation but does not worsen postischemic contractile recovery.
Answers are grounded in this paper and cite their sources.
Metabolic deficits from AMPKα2 deletion do not worsen postischemic recovery in mice; leaves open translational relevance.
AMP-activated protein kinase (AMPK) is a major sensor and regulator of the energetic state of the cell. Little is known about the specific role of AMPKalpha(2), the major AMPK isoform in the heart, in response to global ischemia. We used AMPKalpha(2)-knockout (AMPKalpha(2)(-/-)) mice to evaluate the consequences of AMPKalpha(2) deletion during normoxia and ischemia, with glucose as the sole substrate. Hemodynamic measurements from echocardiography of hearts from AMPKalpha(2)(-/-) mice during normoxia showed no significant modification compared with wild-type animals. In contrast, the response of hearts from AMPKalpha(2)(-/-) mice to no-flow ischemia was characterized by a more rapid onset of ischemia-induced contracture. This ischemic contracture was associated with a decrease in ATP content, lactate production, glycogen content, and AMPKbeta(2) content. Hearts from AMPKalpha(2)(-/-) mice were also characterized by a decreased phosphorylation state of acetyl-CoA carboxylase during normoxia and ischemia. Despite an apparent worse metabolic adaptation during ischemia, the absence of AMPKalpha(2) does not exacerbate impairment of the recovery of postischemic contractile function. In conclusion, AMPKalpha(2) is required for the metabolic response of the heart to no-flow ischemia. The remaining AMPKalpha(1) cannot compensate for the absence of AMPKalpha(2).
No takes yet. Share an insight, caveat, or question.
Zarrinpashneh et al. (2006) studied No-flow ischemia. AMPKalpha(2) deletion vs. Wild-type animals was evaluated on Metabolic response and contractile function during normoxia and ischemia. AMPKalpha(2) deletion in mice resulted in a more rapid onset of ischemia-induced contracture and decreased ATP and glycogen content, but did not exacerbate impairment of postischemic contractile recovery.
Synapse has enriched 10 related papers. Consider them for comparative context: